|
1
|
Prieske K, Alawi M, Oliveira-Ferrer L,
Jaeger A, Eylmann K, Burandt E, Schmalfeldt B, Joosse SA and
Woelber L: Genomic characterization of vulvar squamous cell
carcinoma. Gynecol Oncol. 158:547–554. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dasgupta S, Ewing-Graham PC, Swagemakers
SMA, van der Spek PJ, van Doorn HC, Noordhoek Hegt V, Koljenović S
and van Kemenade FJ: Precursor lesions of vulvar squamous cell
carcinoma-histology and biomarkers: A systematic review. Crit Rev
Oncol Hematol. 147:1028662020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Martel C, Georges D, Bray F, Ferlay J
and Clifford GM: Global burden of cancer attributable to infections
in 2018: A worldwide incidence analysis. Lancet Glob Health.
8:e180–e190. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeimet AG: Molecular characterization of
vulvar squamous cell cancer: High time to gain ground. Gynecol
Oncol. 158:519–520. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han MR, Shin S, Park HC, Kim MS, Lee SH,
Jung SH, Song SY, Lee SH and Chung YJ: Mutational signatures and
chromosome alteration profiles of squamous cell carcinomas of the
vulva. Exp Mol Med. 50:e4422018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weberpals JI, Lo B, Duciaume MM, Spaans
JN, Clancy AA, Dimitroulakos J, Goss GD and Sekhon HS: Vulvar
squamous cell carcinoma (VSCC) as two diseases: HPV status
identifies distinct mutational profiles including oncogenic
fibroblast growth factor receptor 3. Clin Cancer Res. 23:4501–4510.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nooij LS, Ter Haar NT, Ruano D, Rakislova
N, van Wezel T, Smit VTHBM, Trimbos BJBMZ, Ordi J, van Poelgeest
MIE and Bosse T: Genomic characterization of vulvar (Pre)cancers
identifies distinct molecular subtypes with prognostic
significance. Clin Cancer Res. 23:6781–6789. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zieba S, Pouwer AW, Kowalik A, Zalewski K,
Rusetska N, Bakuła-Zalewska E, Kopczyński J, Pijnenborg JMA, de
Hullu JA and Kowalewska M: Somatic mutation profiling in
premalignant lesions of vulvar squamous cell carcinoma. Int J Mol
Sci. 21:48802020. View Article : Google Scholar
|
|
9
|
Williams EA, Werth AJ, Sharaf R, Montesion
M, Sokol ES, Pavlick DC, McLaughlin-Drubin M, Erlich R, Toma H,
Williams KJ, et al: Vulvar squamous cell carcinoma: Comprehensive
genomic profling of HPV+ versus HPV-forms reveals
distinct sets of potentially actionable molecular targets. JCO
Precis Oncol. 4:647–661. 2020. View Article : Google Scholar
|
|
10
|
Tessier-Cloutier B, Kortekaas KE, Thompson
E, Pors J, Chen J, Ho J, Prentice LM, McConechy MK, Chow C, Proctor
L, et al: Major p53 immunohistochemical patterns in in situ and
invasive squamous cell carcinomas of the vulva and correlation with
TP53 mutation status. Mod Pathol. 33:1595–1605. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tessier-Cloutier B, Pors J, Thompson E, Ho
J, Prentice L, McConechy M, Aguirre-Hernandez R, Miller R, Leung S,
Proctor L, et al: Molecular characterization of invasive and in
situ squamous neoplasia of the vulva and implications for
morphologic diagnosis and outcome. Mod Pathol. 34:508–518. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ge Y, Zhang C, Xiao S, Liang L, Liao S,
Xiang Y, Cao K, Chen H and Zhou Y: Identification of differentially
expressed genes in cervical cancer by bioinformatics analysis.
Oncol Lett. 16:2549–2558. 2018.PubMed/NCBI
|
|
13
|
Micci F, Panagopoulos I, Haugom L,
Dahlback HS, Pretorius ME, Davidson B, Abeler VM, Tropé CG,
Danielsen HE and Heim S: Genomic aberration patterns and expression
profiles of squamous cell carcinomas of the vulva. Genes
Chromosomes Cancer. 52:551–563. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang DW, Sherman BT, Tan Q, Kir J, Liu D,
Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC and Lempicki RA:
DAVID bioinformatics resources: Expanded annotation database and
novel algorithms to better extract biology from large gene lists.
Nucleic Acids Res. 35((Web Server Issue)): W169–W175. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47D:D607–D613. 2019.
View Article : Google Scholar
|
|
19
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res.
45W:W98–W102. 2017. View Article : Google Scholar
|
|
20
|
Darragh TM, Colgan TJ, Cox JT, Heller DS,
Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, et
al: The lower anogenital squamous terminology standardization
project for HPV-associated lesions: Background and consensus
recommendations from the college of American pathologists and the
American society for colposcopy and cervical pathology. Arch Pathol
Lab Med. 136:1266–1297. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kortekaas KE, Solleveld-Westerink N,
Tessier-Cloutier B, Rutten TA, Poelgeest MIE, Gilks CB, Hoang LN
and Bosse T: Performance of the pattern-based interpretation of p53
immunohistochemistry as a surrogate for TP53 mutations in vulvar
squamous cell carcinoma. Histopathology. 77:92–99. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Heller DS, Day T, Allbritton JI, Scurry J,
Radici G, Welch K and Preti M; ISSVD Difficult Pathologic Diagnoses
Committee, : Diagnostic criteria for differentiated vulvar
intraepithelial neoplasia and vulvar aberrant maturation. J Low
Genit Tract Dis. 25:57–70. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Sun C, Tan Y, Li L, Zhang H, Liang
Y, Zeng J and Zou H: Transcription levels and prognostic
significance of the NFI family members in human cancers. PeerJ.
8:e88162020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim BR, Coyaud E, Laurent EMN, St-Germain
J, Van de Laar E, Tsao MS, Raught B and Moghal N: Identification of
the SOX2 interactome by BioID reveals EP300 as a mediator of
SOX2-dependent squamous differentiation and lung squamous cell
carcinoma growth. Mol Cell Proteomics. 16:1864–1888. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brustmann H and Brunner A:
Immunohistochemical expression of SOX2 in vulvar intraepithelial
neoplasia and squamous cell carcinoma. Int J Gynecol Pathol.
32:323–328. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu S, Wu Y, Lu Y, Yue Y, Cui C, Yu M, Wang
S, Liu M, Zhao Y and Sun Z: STAT1 expression and HPV16 viral load
predict cervical lesion progression. Oncol Lett.
20:282020.PubMed/NCBI
|
